JW (Cayman) Therapeutics Co. Ltd (JWCTF)
OTCMKTS · Delayed Price · Currency is USD
0.2500
0.00 (0.00%)
Jul 4, 2025, 4:00 PM EDT

JWCTF Statistics

Total Valuation

JWCTF has a market cap or net worth of 150.27 million. The enterprise value is 104.16 million.

Market Cap 150.27M
Enterprise Value 104.16M

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date Aug 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 405.36M
Shares Outstanding n/a
Shares Change (YoY) +0.51%
Shares Change (QoQ) +0.27%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 320.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.93
PB Ratio 0.94
P/TBV Ratio 1.87
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.29
EV / Sales 4.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.24

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.36.

Current Ratio 1.74
Quick Ratio 1.66
Debt / Equity 0.36
Debt / EBITDA n/a
Debt / FCF -1.25
Interest Coverage -37.56

Financial Efficiency

Return on equity (ROE) is -41.40% and return on invested capital (ROIC) is -15.96%.

Return on Equity (ROE) -41.40%
Return on Assets (ROA) -15.00%
Return on Invested Capital (ROIC) -15.96%
Return on Capital Employed (ROCE) -37.77%
Revenue Per Employee 77,140
Profits Per Employee -287,962
Employee Count 281
Asset Turnover 0.08
Inventory Turnover 2.45

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.28% in the last 52 weeks. The beta is 2.21, so JWCTF's price volatility has been higher than the market average.

Beta (5Y) 2.21
52-Week Price Change -12.28%
50-Day Moving Average 0.21
200-Day Moving Average 0.19
Relative Strength Index (RSI) 99.98
Average Volume (20 Days) 125

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, JWCTF had revenue of 21.68 million and -80.92 million in losses. Loss per share was -0.20.

Revenue 21.68M
Gross Profit 10.59M
Operating Income -62.89M
Pretax Income -80.92M
Net Income -80.92M
EBITDA -53.58M
EBIT -62.89M
Loss Per Share -0.20
Full Income Statement

Balance Sheet

The company has 104.47 million in cash and 57.87 million in debt, giving a net cash position of 46.60 million.

Cash & Cash Equivalents 104.47M
Total Debt 57.87M
Net Cash 46.60M
Net Cash Per Share n/a
Equity (Book Value) 160.18M
Book Value Per Share 0.40
Working Capital 47.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -45.68 million and capital expenditures -715,431, giving a free cash flow of -46.40 million.

Operating Cash Flow -45.68M
Capital Expenditures -715,431
Free Cash Flow -46.40M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 48.87%
Operating Margin -290.13%
Pretax Margin -373.30%
Profit Margin n/a
EBITDA Margin -247.18%
EBIT Margin -290.13%
FCF Margin n/a

Dividends & Yields

JWCTF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.51%
Shareholder Yield n/a
Earnings Yield -53.85%
FCF Yield -30.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

JWCTF has an Altman Z-Score of -4.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.42
Piotroski F-Score 3